Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IBRUTINIB vs IMATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IBRUTINIB vs IMATINIB: Safety Overview

Metric IBRUTINIB IMATINIB
Total FAERS Reports 75,087 43,161
Deaths Reported 12,580 13,761
Death Rate 16.8% 31.9%
Hospitalizations 24,920 7,264
Average Patient Age 71.2 yrs 55.7 yrs
% Female Patients 39.2% 47.2%
FDA Approval Date Aug 24, 2022 Apr 14, 2025
Manufacturer Pharmacyclics LLC Dr.Reddy's Laboratories Inc
Route ORAL ORAL
Marketing Status Prescription Discontinued